Skip to main content

Table 2 Factors associated with persistent smoking at the 6-month follow-up visit among the initial current smokers

From: Do patients attempt and succeed in quitting smoking during tuberculosis treatment? A prospective cohort study

Characteristics

All patients

(n = 79)

Persistent smoker

(n = 55)

Smoking quitter

(n = 24)

p-value

Nicotine dependence

   

0.906

 Low

42 (53.2)

29 (52.7)

13 (54.2)

 Moderate/High

37 (46.8)

26 (47.3)

11 (45.8)

Male

73 (92.4)

50 (90.9)

23 (95.8)

0.661

Age < 65 years

67 (84.8)

48 (87.3)

19 (79.2)

0.496

Drinking

   

< 0.05

 Yes

65 (82.3)

50 (90.9)

15 (62.5)

 No

14 (17.7)

5 (9.1)

9 (37.5)

Occupation

   

0.504

 White collar

15 (19.0)

11 (20.0)

4 (16.7)

 Blue collar

35 (44.3)

22 (40.0)

13 (54.2)

 Unemployed

29 (36.7)

22 (40.0)

7 (29.2)

Comorbidities

    

 Diabetes mellitus

11 (13.9)

4 (8.7)

7 (31.8)

< 0.05

 Chronic respiratory diseases

2 (2.5)

0 (0.0)

2 (9.1)

0.090

 Cancer

4 (5.1)

4 (8.5)

0 (0.0)

0.308

Prior tuberculosis history

22 (27.8)

14 (25.5)

8 (33.3)

0.472

Initial symptoms

    

 Cough

45 (57.0)

30 (54.5)

15 (62.5)

0.511

 Dyspnea

15 (19.0)

11 (20.0)

4 (16.7)

1.000

 Chest pain

16 (20.3)

8 (14.5)

8 (33.3)

0.072

Symptoms at 6 months

    

 Cough

14 (17.7)

11 (20.0)

3 (12.5)

0.533

 Dyspnea

9 (11.4)

3 (5.5)

6 (25.0)

< 0.05

 Chest pain

4 (5.1)

4 (7.3)

0 (0.0)

0.308

Microbiologic test results

    

 Positive AFB smear test result

20 (25.3)

12 (21.8)

8 (33.3)

0.279

 Positive AFB culture test result

54 (68.4)

35 (63.6)

19 (79.2)

0.172

 Resistant to either INH or RIF

9 (11.4)

7 (12.7)

2 (8.3)

0.715

Chest x-ray

    

 Bilateral disease on chest x-ray

20 (25.3)

15 (27.3)

5 (20.8)

0.545

 Multi-lobar disease on chest x-ray 1

64 (90.1)

44 (89.8)

20 (90.9)

1.000

  1. AFB, acid-fast bacilli; INH, isoniazid, RIF, rifampicin
  2. Values were expressed as number (percentage) or mean (± standard deviation)
  3. 1 The total number was n = 71